184 related articles for article (PubMed ID: 28203756)
21. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
22. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.
Monaco G; Decrock E; Akl H; Ponsaerts R; Vervliet T; Luyten T; De Maeyer M; Missiaen L; Distelhorst CW; De Smedt H; Parys JB; Leybaert L; Bultynck G
Cell Death Differ; 2012 Feb; 19(2):295-309. PubMed ID: 21818117
[TBL] [Abstract][Full Text] [Related]
23. Targeting the BH3 domain mediated protein-protein interaction of Bcl-xL through virtual screening.
Mukherjee P; Desai P; Zhou YD; Avery M
J Chem Inf Model; 2010 May; 50(5):906-23. PubMed ID: 20392095
[TBL] [Abstract][Full Text] [Related]
24. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB.
Badrichani AZ; Stroka DM; Bilbao G; Curiel DT; Bach FH; Ferran C
J Clin Invest; 1999 Feb; 103(4):543-53. PubMed ID: 10021463
[TBL] [Abstract][Full Text] [Related]
25. A double point mutation at residues Ile14 and Val15 of Bcl-2 uncovers a role for the BH4 domain in both protein stability and function.
Monaco G; La Rovere R; Karamanou S; Welkenhuyzen K; Ivanova H; Vandermarliere E; Di Martile M; Del Bufalo D; De Smedt H; Parys JB; Economou A; Bultynck G
FEBS J; 2018 Jan; 285(1):127-145. PubMed ID: 29131545
[TBL] [Abstract][Full Text] [Related]
26. Evidence for involvement of BH3-only proapoptotic members in adenovirus-induced apoptosis.
Subramanian T; Vijayalingam S; Lomonosova E; Zhao LJ; Chinnadurai G
J Virol; 2007 Oct; 81(19):10486-95. PubMed ID: 17652400
[TBL] [Abstract][Full Text] [Related]
27. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.
Rong YP; Barr P; Yee VC; Distelhorst CW
Biochim Biophys Acta; 2009 Jun; 1793(6):971-8. PubMed ID: 19056433
[TBL] [Abstract][Full Text] [Related]
28. The Bcl-2 proteins Noxa and Bcl-xL co-ordinately regulate oxidative stress-induced apoptosis.
Eno CO; Zhao G; Olberding KE; Li C
Biochem J; 2012 May; 444(1):69-78. PubMed ID: 22380599
[TBL] [Abstract][Full Text] [Related]
29. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
Yang MC; Loh JK; Li YY; Huang WS; Chou CH; Cheng JT; Wang YT; Lieu AS; Howng SL; Hong YR; Chou AK
Int J Oncol; 2015 Mar; 46(3):1304-16. PubMed ID: 25586056
[TBL] [Abstract][Full Text] [Related]
30. Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.
Trisciuoglio D; De Luca T; Desideri M; Passeri D; Gabellini C; Scarpino S; Liang C; Orlandi A; Del Bufalo D
Neoplasia; 2013 Mar; 15(3):315-27. PubMed ID: 23479509
[TBL] [Abstract][Full Text] [Related]
31. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
Schmitt E; Paquet C; Beauchemin M; Bertrand R
Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082
[TBL] [Abstract][Full Text] [Related]
32. Probing Gallate-Mediated Selectivity and High-Affinity Binding of Epigallocatechin Gallate: a Way-Forward in the Design of Selective Inhibitors for Anti-apoptotic Bcl-2 Proteins.
Olotu FA; Agoni C; Adeniji E; Abdullahi M; Soliman ME
Appl Biochem Biotechnol; 2019 Mar; 187(3):1061-1080. PubMed ID: 30155742
[TBL] [Abstract][Full Text] [Related]
33. Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells.
Aranovich A; Liu Q; Collins T; Geng F; Dixit S; Leber B; Andrews DW
Mol Cell; 2012 Mar; 45(6):754-63. PubMed ID: 22464442
[TBL] [Abstract][Full Text] [Related]
34. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members.
Hsu SY; Lin P; Hsueh AJ
Mol Endocrinol; 1998 Sep; 12(9):1432-40. PubMed ID: 9731710
[TBL] [Abstract][Full Text] [Related]
35. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1.
Yasuda M; Chinnadurai G
Oncogene; 2000 May; 19(19):2363-7. PubMed ID: 10822388
[TBL] [Abstract][Full Text] [Related]
36. Boo, a novel negative regulator of cell death, interacts with Apaf-1.
Song Q; Kuang Y; Dixit VM; Vincenz C
EMBO J; 1999 Jan; 18(1):167-78. PubMed ID: 9878060
[TBL] [Abstract][Full Text] [Related]
37. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.
Lebedeva I; Rando R; Ojwang J; Cossum P; Stein CA
Cancer Res; 2000 Nov; 60(21):6052-60. PubMed ID: 11085527
[TBL] [Abstract][Full Text] [Related]
38. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
Fiebig AA; Zhu W; Hollerbach C; Leber B; Andrews DW
BMC Cancer; 2006 Aug; 6():213. PubMed ID: 16928273
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2 family members as molecular targets in cancer therapy.
Marzo I; Naval J
Biochem Pharmacol; 2008 Oct; 76(8):939-46. PubMed ID: 18638457
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis.
Zhou F; Yang Y; Xing D
FEBS J; 2011 Feb; 278(3):403-13. PubMed ID: 21182587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]